Joinn Laboratories(China)Co.,Ltd. (6127.HK) HKSE
21.22
+0.3(+1.43%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
21.22
+0.3(+1.43%)
Currency In HKD
Address
A5 Rongjing East Street
Beijing, 100176
China
Phone
86 10 6786 9966
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
2510
First IPO Date
February 26, 2021
| Name | Title | Pay | Year Born |
| Dalin Yao | Chief Scientific Officer | 0 | 1949 |
| Yunxia Sun | Vice GM & Executive Director | 0 | 1968 |
| Dapeng Gao | GM, Secretary to the Board, Joint Company Secretary & Executive Director | 0 | 1982 |
| Jingliang Gu | Vice GM, Head of Sales Department and Executive Director | 0 | 1980 |
| Aishui Yu | Chief Financial Officer | 0 | 1976 |
| Xi Luo | Executive Director | 0 | 1977 |
| Yuxia Feng | Founder & Chairman | 0 | 1964 |
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.